Najlepsze podcasty z kategorii: Lancet (2022)

L

Listen to The Lancet Neurology

1
In conversation with... Laurent Servais and Dora Markati

4d ago

—

Laurent Servais and Dora Markati (both from the University of Oxford, UK) discuss emerging therapies for Duchenne muscular dystrophy; their Review is published in the September issue of The Lancet Neurology.Autor: The Lancet

T

The Lancet Voice

1
Monkeypox: an African perspective 30:04

6d ago30:04

30:04

What’s happening with monkeypox in Africa? Why wasn’t monkeypox tackled when we had the chance? What will the PHEIC declaration change? Prof. Yap Boum, Epicentre Representative for Africa, the research arm of Medecins sans Frontières, joins Gavin and guest host Dr. Miriam Lewis Sabin to discuss. You can read The Lancet's collection of articles on m…

L

Listen to The Lancet Gastroenterology & Hepatology

1
In conversation with... Edward Kim 14:06

10d ago14:06

14:06

Edward Kim (Icahn School of Medicine at Mount Sinai) discusses the single-arm RASER study of radiation segmentectomy for patients with unresectable very early to early stage hepatocellular carcinoma.Autor: The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Rachael Evans 13:28

20d ago13:28

13:28

Rachael Evans discusses the needs of people with long COVID and the latest findings from the PHOSP-COVID study.Autor: The Lancet

L

Listen to The Lancet HIV

1
In conversation with... Amir Mohareb 12:09

20d ago12:09

12:09

Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B.Autor: The Lancet

L

Listen to The Lancet Oncology

1
In conversation with... Ignace Vergote and Maria Kyrgiou 10:30

21d ago10:30

10:30

Ignace Vergote (Belgium and Luxembourg Gynaecological Oncology Group, Leuven, Belgium) and Maria Kyrgiou (Imperial College London, London, UK) discuss their Series papers on gynaecological cancers.Autor: The Lancet

L

Listen to The Lancet Diabetes & Endocrinology

1
In conversation with... Niki Karavitaki 9:42

27d ago9:42

9:42

Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma.Autor: The Lancet

L

Listen to The Lancet Infectious Diseases

1
In conversation with... Ben Cowling 20:58

1M ago20:58

20:58

Ben Cowling discusses a new article in The Lancet Infectious Diseases describing the protection that vaccines are providing against COVID-19 in Hong Kong.Autor: The Lancet

T

The Lancet Voice

1
Marking South Asian Heritage Month and discussing GRacE 33:21

20d ago33:21

33:21

Mandip Aujla talks to Binita Kane, co-founder of South Asian Heritage Month, about South Asian culture, history, and community, and the two new chairs of the Lancet's Group for Racial Equality discuss the group's work on diversity and inclusion. Find out more about South Asian Heritage Month here You can continue the conversation with Jessamy and G…

L

Listen to The Lancet Neurology

1
In conversation with... Andreas Charidimou 22:58

1M ago22:58

22:58

Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology.Autor: The Lancet

L

Listen to The Lancet Child & Adolescent Health

1
In conversation with... Laura Aguirre-Martínez, Ziyu Peng, and Kareem Zudi 15:47

1M ago15:47

15:47

Our Youth Advisory Panel members join Jane Godsland to discuss the effects of the COVID-19 pandemic on young lives.Autor: The Lancet

T

The Lancet Voice

1
Measuring impact 37:08

1M ago37:08

37:08

Nine Lancet journals are top of their categories for Impact Factor in the latest measurements. What is the value of Impact Factors? What do they capture, and what don’t they capture? Richard Horton, editor-in-chief of The Lancet, joins Gavin and Jessamy to discuss impact. You can continue the conversation with Jessamy and Gavin on Twitter by follow…

L

Listen to The Lancet Gastroenterology & Hepatology

1
In conversation with... Joep Ijspeert 10:26

1M ago10:26

10:26

Joep Ijspeert (Amsterdam University Medical Center) discusses a population-based study exploring the detection of proximal serrated polyps and interval post-colonoscopy colorectal cancer risk.Autor: The Lancet

L

Listen to The Lancet HIV

1
In conversation with... Kenneth Ngure 12:00

1M ago12:00

12:00

Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing.Autor: The Lancet

L

Listen to The Lancet Oncology

1
In conversation with... David J Pinato 5:19

2M ago5:19

5:19

David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe.Autor: The Lancet

L

Listen to The Lancet Haematology

1
In conversation with... Amy DeZern 12:50

2M ago12:50

12:50

Dr Amy DeZern discusses the link between myelodysplastic syndrome and autoimmune disorders and the need for a multidisciplinary approach for the treatment of patients who have both.Autor: The Lancet

T

The Lancet Voice

1
Mental health and HIV 28:13

2M ago28:13

28:13

Poor mental health can contribute to HIV risk and affect outcomes of HIV care, and living with HIV or risk of HIV can contribute to poor mental health. Editor-in-chief of The Lancet HIV, Peter Hayward, joins Gavin and Jessamy to discuss new research on the overlapping issues and where the opportunities for improving care can be found. Read the Seri…

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Daniel Munblit and Dale Needham 16:37

2M ago16:37

16:37

Daniel Munblit and Dale Needham discuss the importance of developing a core outcome set for post-COVID-19 condition.Autor: The Lancet

L

Listen to The Lancet Neurology

1
In conversation with... Sarah Tabrizi and Cristina Sampaio 18:52

2M ago18:52

18:52

Sarah Tabrizi (UCL Queen Square Institute of Neurology, London, UK) and Cristina Sampaio (CHDI Foundation, Princeton, NJ, USA) discuss two papers on Huntington’s disease published in the July issue of The Lancet Neurology: a Position Paper outlining a new classification of the disease, called the Huntington’s Disease Integrated Staging System, and …

L

Listen to The Lancet Child & Adolescent Health

1
In conversation with... Bridget Bould, Tariro Kambeu, and Chiamaka Nwachukwu 18:07

2M ago18:07

18:07

Our Youth Advisory Panel members Bridget Bould, Tariro Kambeu, and Chiamaka Nwachukwu join Esther Lau to discuss nutrition in children and young people.Autor: The Lancet

L

Listen to The Lancet Gastroenterology & Hepatology

1
In conversation with... Elise Meima-van Praag 9:50

2M ago9:50

9:50

Elise Meima-van Praag (Amsterdam University Medical Centre) discusses the PISA-II trial, investigating short-term anti-TNF therapy with surgical closure versus anti-TNF therapy for perianal fistulas in Crohn's disease.Autor: The Lancet

L

Listen to The Lancet Global Health

1
In conversation with... Olusegun Alatise 14:27

2M ago14:27

14:27

Mandip Aujla talks to Olusegun Alatise about colorectal cancer screening in Nigeria.Autor: The Lancet

T

The Lancet Voice

1
Smell disorders and COVID-19 30:49

2M ago30:49

30:49

How many people have had their sense of smell affected in the long-term by COVID-19? What does it mean for them? Did some COVID-19 waves have a greater effect on sense of smell than others? How can people regain their sense of smell? Prof. Carl Philpott joins Gavin and Jessamy to discuss anosmia and parosmia.…

L

Listen to The Lancet HIV

1
In conversation with... Marta Vasylyev and Casper Rokx 21:14

2M ago21:14

21:14

Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine.Autor: The Lancet

T

The Lancet Voice

1
Syria and enabling local humanitarian efforts in warzones 27:02

3M ago27:02

27:02

Rola Hallam joins Gavin to talk about her path from being a Syrian refugee in the UK to running CanDo, a humanitarian organisation enabling local relief efforts, and the lessons for aid in warzones and protecting healthcare from attack. You can continue the conversation with Jessamy and Gavin on Twitter by following them at @JessamyBagenal and @Gav…

L

Listen to The Lancet Infectious Diseases

1
In conversation with... Hugh Adler 18:17

3M ago18:17

18:17

Hugh Adler discusses a new article in The Lancet Infectious Diseases describing the management and the clinical features for seven patients with monkeypox hospitalised in the UK between 2018 and 2021.Autor: The Lancet

L

Listen to The Lancet Diabetes & Endocrinology

1
In conversation with... Rossella Nappi 17:28

3M ago17:28

17:28

Rossella Nappi talks with The Lancet Diabetes & Endocrinology about cardiometabolic changes that occur during the menopausal transition and implications for women’s health.Autor: The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Daiana Stolz 10:16

3M ago10:16

10:16

Daiana Stolz discusses antibiotic stewardship in patients hospitalised with pneumonia and at risk of Gram-negative bacterial infection.Autor: The Lancet

T

The Lancet Voice

1
Health and politics 48:44

3M ago48:44

48:44

How does health shape politics? How does politics shape health? Why do some diseases get international attention and funding when others don’t? What role do institutions play? Richard Horton, Eduardo Gomez, and Jeremy Shiffman join Jessamy and Gavin to discuss the talking points from a new Lancet Series on Political Science and Health. Read the ful…

L

Listen to The Lancet

1
Health and politics 48:44

3M ago48:44

48:44

How does health shape politics? How does politics shape health? Why do some diseases get international attention and funding when others don’t? What role do institutions play? Richard Horton, Eduardo Gomez, and Jeremy Shiffman join Jessamy and Gavin to discuss the talking points from a new Lancet Series on Political Science and Health.…

L

Listen to The Lancet Neurology

1
In conversation with... Mark Hallett 8:43

3M ago8:43

8:43

Mark Hallett (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA) discusses his Review, published in the June issue of The Lancet Neurology, on functional neurological disorder, and talks about new subtypes of this disorder, diagnostic challenges, and how education is important.…

L

Listen to The Lancet Global Health

1
In conversation with... Melanie Lowe and Deepti Adlakha 21:04

3M ago21:04

21:04

Nina Putnis talks to two of the authors of the new Series on urban design, transport, and health, Melanie Lowe and Deepti Adlakha.Autor: The Lancet

L

Listen to The Lancet Gastroenterology & Hepatology

1
In conversation with... Juan Pablo Arab 17:06

3M ago17:06

17:06

Juan Pablo Arab (Catholic University of Chile) discusses the current burden of NAFLD and the landscape of public health policies related to the disease in the Americas.Autor: The Lancet

L

Listen to The Lancet Child & Adolescent Health

1
In conversation with... Hamaiyal Sana and Egle Janusonyte 33:59

3M ago33:59

33:59

Our Youth Advisory Panel members Hamaiyal Sana and Egle Janusonyte join Sophia Davis to discuss gender equity in young people’s sexual and reproductive health and rights.Autor: The Lancet

L

Listen to The Lancet Oncology

1
In conversation with... Wilfred Ngwa, Beatrice Wiafe-Addai, and David Kerr 30:55

3M ago30:55

30:55

Wilfred Ngwa (Harvard Medical School, Boston, MA, USA; Johns Hopkins University, Baltimore, MD, USA; ICT University, Yaounde, Cameroon), Beatrice Wiafe-Addai (Peace and Love Hospital, Kumasi, Ghana), and David Kerr (University of Oxford, Oxford, UK) discuss the Lancet Oncology Commission on cancer in sub-Saharan Africa.…

T

The Lancet Voice

1
The past and future of child health, with Richard Horton 17:59

3M ago17:59

17:59

In 2019 there were 8.6m deaths globally among children and adolescents aged 0-20 years. Almost two decades on from The Lancet’s first ever global health series, on child survival, we've published our new Series, Optimising Child and Adolescent Health and Development. Richard Horton reflects on the progress and setbacks across 20 years of child heal…

L

Listen to The Lancet

1
The past and future of child health, with Richard Horton 17:59

3M ago17:59

17:59

In 2019 there were 8.6m deaths globally among children and adolescents aged 0-20 years. Almost two decades on from The Lancet’s first ever global health series, on child survival, we've published our new Series, Optimising Child and Adolescent Health and Development. Richard Horton reflects on the progress and setbacks across 20 years of child heal…

L

Listen to The Lancet HIV

1
In conversation with... Angela Colbers and Hylke Waalewijn 19:47

3M ago19:47

19:47

Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV.Autor: The Lancet

L

Listen to The Lancet Oncology

1
In conversation with... Georgios Lyratzopoulos 13:44

4M ago13:44

13:44

Georgios Lyratzopoulos (Institute of Epidemiology & Health Care at University College London, London, UK) discusses his population-based study on risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission.Autor: The Lancet

T

The Lancet Voice

1
Misinformation, health, and social media 21:59

4M ago21:59

21:59

Imran Ahmed, CEO of the Center For Countering Digital Hate, joins the podcast to discuss the proliferation of misinformation across social media, how medical misinformation has become a profitable industry, why it's been allowed, and what can be done. Read the CCDH's reports, The Disinformation Dozen and Pandemic Profiteers. You can continue the co…

L

Listen to The Lancet Diabetes & Endocrinology

1
In conversation with... Louise Baur 11:26

4M ago11:26

11:26

Louise Baur talks with The Lancet Diabetes & Endocrinology about the prevalence and causes of child and adolescent obesity, and the need for personalised treatment approaches.Autor: The Lancet

L

Listen to The Lancet Neurology

1
In conversation with... Eva Feldman 22:43

4M ago22:43

22:43

Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.Autor: The Lancet

T

The Lancet Voice

1
Omicron in Hong Kong 25:33

4M ago25:33

25:33

Prof. Gabriel Leung, Dean of Medicine at the University of Hong Kong, joins Gavin and Jessamy to discuss Hong Kong's recent Omicron wave of COVID-19 and what this variant means for health systems and zero-COVID containment approaches. You can continue the conversation with Jessamy and Gavin on Twitter by following them at @JessamyBagenal and @Gavin…

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Ablo Wachinou 10:39

4M ago10:39

10:39

Dr Ablo Wachinou discusses the prevalence of sleep disordered breathing in Benin and how awareness and treatment might be improved.Autor: The Lancet

L

Listen to The Lancet Respiratory Medicine

1
In conversation with... Peter Openshaw and Felicity Liew 14:46

4M ago14:46

14:46

Professor Peter Openshaw and Dr Felicity Liew discuss the use of inhaled corticosteroids in the early treatment of COVID and the involvement of the respiratory mucosa in response to viral infection.Autor: The Lancet

L

Listen to The Lancet Gastroenterology & Hepatology

1
In conversation with... Sarah Blach 8:57

4M ago8:57

8:57

Sarah Blach (CDA Foundation) summarises the latest analysis of global hepatitis C virus epidemiology and cascade of care by the Polaris Observatory HCV Collaborators.Autor: The Lancet

L

Listen to The Lancet Neurology

1
In conversation with... Estrella Morenas-Rodriguez and Christian Haass 27:15

4M ago27:15

27:15

Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology, on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition.Autor: The Lancet

L

Listen to The Lancet Global Health

1
In conversation with... Kara Hanson 19:19

4M ago19:19

19:19

Zoë Mullan talks to lead author Kara Hanson about the main findings and recommendations of the Commission on financing primary health care.Autor: The Lancet

L

Listen to The Lancet Oncology

1
In conversation with... Lisa Iezzoni and Jordan Marchak 12:53

5M ago12:53

12:53

Lisa Iezzoni (Massachusetts General Hospital, Boston, MA, USA) discusses her Series paper on disabilities and cancer and Jordan Marchak (Children’s Healthcare of Atlanta, Atlanta, GA, USA) discusses her Review on surveillance of mental health problems in childhood, adolescent, and young adult cancer survivors.…

L

Listen to The Lancet Gastroenterology & Hepatology

1
In conversation with... Sunil Solomon 15:02

5M ago15:02

15:02

Sunil Solomon (Johns Hopkins University) discusses a study of a minimal monitoring approach for treating patients with hepatitis C virus infection.Autor: The Lancet

Podcasty warte posłuchania

SPONSOROWANY

Lancet Podcasty

Download the App!

Podcasty warte posłuchania

SPONSOROWANY

Skrócona instrukcja obsługi